Your browser doesn't support javascript.
loading
Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
Hall, A R; Burke, N; Dongworth, R K; Kalkhoran, S B; Dyson, A; Vicencio, J M; Dorn, G W; Yellon, D M; Hausenloy, D J.
Afiliación
  • Hall AR; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Burke N; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Dongworth RK; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Kalkhoran SB; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Dyson A; Division of Medicine, University College London, London, UK.
  • Vicencio JM; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Dorn GW; Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA.
  • Yellon DM; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Hausenloy DJ; The Hatter Cardiovascular Institute, University College London, London, UK. d.hausenloy@ucl.ac.uk.
Cell Death Dis ; 12(7): 660, 2021 Jun 30.
Article en En | MEDLINE | ID: mdl-34193829

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cell Death Dis Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cell Death Dis Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido